Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
- Study Title
- Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
- Teva Identifier
- IXR-202-22-188
- ClinicalTrials.gov Identifier
- NCT00104091
- Study Status
- Completed
- Trial Condition(s)
- Glioblastoma Multiforme
- Interventions
- Drug: TP-38
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 12/01/2004 - 06/01/2007
- Phase
- Phase 2
